What Clinical Trials Can Teach Us about the Development of More Resilient AI for Cybersecurity

Edmon Begoli; Robert A. Bridges; Sean Oesch; Kathryn E. Knight

What Clinical Trials Can Teach Us about the Development of More Resilient AI for Cybersecurity

Edmon Begoli, Robert A. Bridges, Sean Oesch, Kathryn E. Knight

Research output: Working paper › Preprint

1 Downloads (Pure)

Abstract

Policy-mandated, rigorously administered scientific testing is needed to provide transparency into the efficacy of artificial intelligence-based (AI-based) cyber defense tools for consumers and to prioritize future research and development. In this article, we propose a model that is informed by our experience, urged forward by massive scale cyberattacks, and inspired by parallel developments in the biomedical field and the unprecedentedly fast development of new vaccines to combat global pathogens.

Original language	English
State	Published - May 13 2021

Keywords

cs.CR

Access to Document

2105.06545v1

Cite this

@techreport{7533139bf1be42f28e5978618b1e4da4,

title = "What Clinical Trials Can Teach Us about the Development of More Resilient AI for Cybersecurity",

abstract = "Policy-mandated, rigorously administered scientific testing is needed to provide transparency into the efficacy of artificial intelligence-based (AI-based) cyber defense tools for consumers and to prioritize future research and development. In this article, we propose a model that is informed by our experience, urged forward by massive scale cyberattacks, and inspired by parallel developments in the biomedical field and the unprecedentedly fast development of new vaccines to combat global pathogens. ",

keywords = "cs.CR",

author = "Edmon Begoli and Bridges, {Robert A.} and Sean Oesch and Knight, {Kathryn E.}",

year = "2021",

month = may,

day = "13",

language = "English",

type = "WorkingPaper",

}

TY - UNPB

T1 - What Clinical Trials Can Teach Us about the Development of More Resilient AI for Cybersecurity

AU - Begoli, Edmon

AU - Bridges, Robert A.

AU - Oesch, Sean

AU - Knight, Kathryn E.

PY - 2021/5/13

Y1 - 2021/5/13

N2 - Policy-mandated, rigorously administered scientific testing is needed to provide transparency into the efficacy of artificial intelligence-based (AI-based) cyber defense tools for consumers and to prioritize future research and development. In this article, we propose a model that is informed by our experience, urged forward by massive scale cyberattacks, and inspired by parallel developments in the biomedical field and the unprecedentedly fast development of new vaccines to combat global pathogens.

AB - Policy-mandated, rigorously administered scientific testing is needed to provide transparency into the efficacy of artificial intelligence-based (AI-based) cyber defense tools for consumers and to prioritize future research and development. In this article, we propose a model that is informed by our experience, urged forward by massive scale cyberattacks, and inspired by parallel developments in the biomedical field and the unprecedentedly fast development of new vaccines to combat global pathogens.

KW - cs.CR

M3 - Preprint

BT - What Clinical Trials Can Teach Us about the Development of More Resilient AI for Cybersecurity

ER -

What Clinical Trials Can Teach Us about the Development of More Resilient AI for Cybersecurity

Abstract

Keywords

Access to Document

Fingerprint

Cite this